ELRIG UK has partnered with The Protein Society (TPS) to provide forums for the advancement of research into protein structure, function, design and applications. The partners will collaborate to deliver a joint conference on ‘Protein Sciences in Drug Discovery’, bringing together their respective communities to focus on… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It is also available to watch as a vodcast: This week… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week has seen some exciting advances in neuroscience drug discovery, including Phase II… Read More
Software company Proscia has partnered with spatial AI biomarker company Nucleai in a collaboration aimed at improving precision medicine biomarkers for clinical trials. The companies are integrating Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and will make them available as part of Proscia’s precision medicine… Read More
Following a trip to Copenhagen, Denmark, DDW’s Megan Thomas reflects on the Novo Nordisk Foundation’s efforts to tackle cardiometabolic diseases. According to presentations given at the Foundation’s HQ, more than 30% of the world’s population is overweight or obese and 537 million people live with… Read More
Resolution Therapeutics has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence a Phase I/II EMERALD study for its lead candidate RTX001 for patients with decompensated liver cirrhosis. EMERALD is an open-label, Phase I/II study which will investigate the safety and… Read More
DDW’s Megan Thomas shines a spotlight on Rohan Thakur, President of Bruker Daltonics, as part of the first episode of the From the Top vodcast series. This interview took place while attending the opening of Bruker Corporation’s new production facility in Bremen. MT: What has you career path… Read More
The first episode of the DDW From the Top vodcast features Dr Rohan Thakur, President of Bruker Daltonics. Dr Thakur discusses the intersection of science and business, sharing his experiences and insights on how to navigate this intersection. He reflects on his career path, highlighting… Read More
This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers three articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Medicinal cannabis: Why more clinical… Read More
This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers three articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Medicinal cannabis: Why more clinical… Read More
Download the exclusive Guide and read about: Where is the global innovation and opportunity in cancer drug discovery? How is technology expediting the development of new cancer drugs? CRISPR-Cas and its use in cancer research What lies ahead for cancer research?… Read More
With debilitating symptoms including tremor, slow movement, rigidness and pain, Parkinson’s disease remains one of the most feared neurodegenerative conditions. DDW’s Megan Thomas reports on the latest clinical progress as pharma and biotech search for new therapies for this currently incurable condition. Parkinson’s is the most common movement disorder, affecting… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It’s been another busy week in the world of cell therapy, with the first… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It’s been another busy week in the world of cell therapy, with the first… Read More
iOnctura has closed an €80 million Series B financing to continue developing a portfolio of precision oral small molecules that target cancers in novel ways. The funding round was led by new investor Syncona Limited with participation by the EIC Fund, the venture arm of the… Read More
Destiny Pharma has announced new data on one of its compounds, XF-70, which has demonstrated potency in an in vivo model of ringworm, a common fungal skin infection, which affects up to one in four people worldwide. Ringworm is caused by a class of fungi called… Read More
